Furthermore, we assessed the mutation frequency of 18 prognosis‐related PRGs in STAD, finding that only seven of these genes exhibited a mutation frequency greater than 1%, such as MAGED1, SNAI2, NTRK1, and NGF (Figure 1d). This evidence concerns the gene MAGED1 and gastric adenocarcinoma.